Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,391 | 2,823 | 3,240 | 4,568 | 3,006 |
| Receivables | N/A | N/A | 1,000 | 100 | 525 |
| Other current assets | 11 | 11 | 11 | 11 | 27 |
| TOTAL | $1,514 | $3,089 | $4,635 | $5,065 | $4,020 |
| Non-Current Assets | |||||
| PPE Net | 66 | 66 | N/A | N/A | N/A |
| Investments And Advances | 5,350 | 5,350 | 5,350 | 5,350 | 5,350 |
| TOTAL | $5,416 | $5,416 | $5,350 | $5,350 | $5,350 |
| Total Assets | $6,930 | $8,505 | $9,985 | $10,415 | $9,370 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,597 | 457 | 508 | 480 | 462 |
| Accrued Expenses | 246 | 1,257 | 392 | 397 | 338 |
| TOTAL | $1,843 | $1,714 | $900 | $877 | $800 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,843 | $1,714 | $900 | $877 | $800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,681 | 4,330 | 4,330 | 3,925 | 3,337 |
| Retained earnings | -275,952 | -274,197 | -271,020 | -270,221 | -269,245 |
| TOTAL | $5,087 | $6,791 | $9,085 | $9,538 | $8,570 |
| Total Liabilities And Equity | $6,930 | $8,505 | $9,985 | $10,415 | $9,370 |